SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Jensen-Urstad, K
Right arrow Articles by Frostegard, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jensen-Urstad, K
Right arrow Articles by Frostegard, J
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease

K Jensen-Urstad

Cardiovascular Laboratory, Department of Medicine, Karolinska Institute at Karolinska Hospital, Stockholm, Sweden

E Svenungsson

Department of Rheumatology and Centre for Molecular Medicine, Karolinska Institute at Karolinska Hospital, Stockholm, Sweden

U de Faire

Cardiovascular Laboratory, Department of Medicine; Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institute at Karolinska Hospital, Stockholm, Sweden

A Silveira

Department of Cardiology and King Gustaf V Research Institute, Karolinska Institute at Karolinska Hospital, Stockholm, Sweden

J L Witztum

Department of Medicine, University of California, San Diego, CA, USA

A Hamsten

Department of Cardiology and King Gustaf V Research Institute, Karolinska Institute at Karolinska Hospital, Stockholm, Sweden

J Frostegard

Department of Rheumatology and Centre for Molecular Medicine, Karolinska Institute at Karolinska Hospital, Stockholm, Sweden

The objective of this study was to study cardiac valve morphology and function and ventricular function in systemic lupus erythematosus(SLE) patients with and without co-existingcardiovascular disease (CVD) and in populationcontrols.Twenty-six women (52§ 8.2 years) with SLE (SLE cases) and a history of CVD (angina pectoris, myocardial infarction, cerebral infarction or intermittent claudication) were compared with 26 age-matched women with SLE but without manifest CVD (SLE controls) and 26 age-matched control women (population controls). Echocardiography was performed to assess valvular abnormalities and manifestations of ischaemic heart disease. Thirteen of the 26 SLE cases but only one of the SLE controls and one of the population controls had cardiac valvularabnormalities.Three of the SLE cases had already undergonevalve replacement and another had significant aortic insufficiency; the other nine had thickening of mainly mitral leaflets without hemodynamic significance. Among SLE cases, patients with valvular abnormalities had higher homocysteine (P < 0.001) and triglyceride (P=0.02) concentrations than patients without valvular disease. In contrast atherosclerosis as determined by IMT, oxidized LDL as measured by the monoclonal antibody E06, autoantibodiesagainst epitopesof OxLDL (aOxLDL) or phospholipids (aPL), disease duration or activity, or acute phase reactants did not differ between SLE cases with or without valvular abnormalities.Valvular abnormalitieswere not more common in SLE cases with stroke as compared to those with myocardial infarction, angina or claudication. In conclusion, valvular abnormalities are strongly associated with CVD in SLE. Raised levels of homocysteine and triglycerides characterize patients with cardiac valve abnormalities.

Key Words: atherosclerosis • cardiac valve • echocardiography • systemic lupus erythematosus

Lupus, Vol. 11, No. 11, 744-752 (2002)
DOI: 10.1191/0961203302lu254oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
D Jain and M K Halushka
Cardiac pathology of systemic lupus erythematosus
J. Clin. Pathol., July 1, 2009; 62(7): 584 - 592.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A N Kiani, E K Fishman, and M Petri
Aortic valve calcification in systemic lupus erythematosus
Lupus, December 1, 2006; 15(12): 873 - 876.
[Abstract] [PDF]


Home page
LupusHome page
A Doria, L Iaccarino, P Sarzi-Puttini, F Atzeni, M Turriel, and M Petri
Cardiac involvement in systemic lupus erythematosus
Lupus, September 1, 2005; 14(9): 683 - 686.
[Abstract] [PDF]


Home page
Journal of the American Dental AssociationHome page
E. LESSARD, M. GLICK, S. AHMED, and M. SARIC
The patient with a heart murmur: Evaluation, assessment and dental considerations
J Am Dent Assoc, March 1, 2005; 136(3): 347 - 356.
[Abstract] [Full Text] [PDF]



Advertisement